117 related articles for article (PubMed ID: 33623437)
1. Association Between Single-Nucleotide Polymorphisms in Breast Cancer Susceptibility Genes and Clinicopathological Characteristics.
Wang S; Zhang K; Tang L; Yang Y; Wang H; Zhou Z; Pang J; Chen F
Clin Epidemiol; 2021; 13():103-112. PubMed ID: 33623437
[TBL] [Abstract][Full Text] [Related]
2. Association of Single-Nucleotide Polymorphisms in Monoubiquitinated FANCD2-DNA Damage Repair Pathway Genes With Breast Cancer in the Chinese Population.
Chen FY; Wang H; Li H; Hu XL; Dai X; Wang SM; Yan GJ; Jiang PL; Hu YP; Huang J; Tang LL
Technol Cancer Res Treat; 2018 Jan; 17():1533033818819841. PubMed ID: 30799775
[TBL] [Abstract][Full Text] [Related]
3. Two tSNPs in BRIP1 are associated with breast cancer during TDT analysis.
Li X; Li Z; Yang M; Luo Y; Hu L; Xiao Z; Huang A; Huang J
Mol Genet Genomic Med; 2021 Feb; 9(2):e1578. PubMed ID: 33403820
[TBL] [Abstract][Full Text] [Related]
4. Haplotype analysis of eight genes of the monoubiquitinated FANCD2-DNA damage-repair pathway in breast cancer patients.
Tang LL; Chen FY; Wang H; Hu XL; Dai X; Mao J; Shen ZT; Wu YH; Wang SM; Hai J; Yan GJ; Li H; Huang J
Cancer Epidemiol; 2013 Jun; 37(3):311-7. PubMed ID: 23357080
[TBL] [Abstract][Full Text] [Related]
5. Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer.
Song H; Ramus SJ; Kjaer SK; Hogdall E; Dicioccio RA; Whittemore AS; McGuire V; Hogdall C; Jacobs IJ; Easton DF; Ponder BA; Dunning AM; Gayther SA; Pharoah PD
PLoS One; 2007 Mar; 2(3):e268. PubMed ID: 17342202
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer].
Liu ZF; Chen C; Yao XL; Sun SR
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features of indonesian breast cancers with different molecular subtypes.
Widodo I; Dwianingsih EK; Triningsih E; Utoro T; Soeripto
Asian Pac J Cancer Prev; 2014; 15(15):6109-13. PubMed ID: 25124582
[TBL] [Abstract][Full Text] [Related]
8. Impact on breast cancer susceptibility and clinicopathological traits of common genetic polymorphisms in
Floris M; Pira G; Castiglia P; Idda ML; Steri M; De Miglio MR; Piana A; Cossu A; Azara A; Arru C; Deiana G; Putzu C; Sanna V; Carru C; Serra A; Bisail M; Muroni MR
Oncol Lett; 2022 Oct; 24(4):331. PubMed ID: 36039053
[TBL] [Abstract][Full Text] [Related]
9. Lymph node status in different molecular subtype of breast cancer: triple negative tumours are more likely lymph node negative.
Liu N; Yang Z; Liu X; Niu Y
Oncotarget; 2017 Aug; 8(33):55534-55543. PubMed ID: 28903439
[TBL] [Abstract][Full Text] [Related]
10. Differential impact of body mass index and its change on the risk of breast cancer by molecular subtype: A case-control study in Japanese women.
Sueta A; Ito H; Islam T; Hosono S; Watanabe M; Hirose K; Fujita T; Yatabe Y; Iwata H; Tajima K; Tanaka H; Iwase H; Matsuo K
Springerplus; 2012 Dec; 1(1):39. PubMed ID: 23350064
[TBL] [Abstract][Full Text] [Related]
11. Associations between body mass index and molecular subtypes as well as other clinical characteristics of breast cancer in Chinese women.
Chen FY; Ou HY; Wang SM; Wu YH; Yan GJ; Tang LL
Ther Clin Risk Manag; 2013; 9():131-7. PubMed ID: 23576872
[TBL] [Abstract][Full Text] [Related]
12. Case-only analyses of the associations between polymorphisms in the metastasis-modifying genes BRMS1 and SIPA1 and breast tumor characteristics, lymph node metastasis, and survival.
Roberts MR; Hong CC; Edge SB; Yao S; Bshara W; Higgins MJ; Freudenheim JL; Ambrosone CB
Breast Cancer Res Treat; 2013 Jun; 139(3):873-85. PubMed ID: 23771732
[TBL] [Abstract][Full Text] [Related]
13. The association between body mass index and immunohistochemical subtypes in breast cancer.
Sahin S; Erdem GU; Karatas F; Aytekin A; Sever AR; Ozisik Y; Altundag K
Breast; 2017 Apr; 32():227-236. PubMed ID: 27756509
[TBL] [Abstract][Full Text] [Related]
14. [Association of single nucleotide polymorphisms in PAI-1 with breast cancer susceptibility and prognosis].
Chen YL; Jia YM; Xie YT; Li Y; Fang WG; Tian XX
Zhonghua Bing Li Xue Za Zhi; 2016 Aug; 45(8):533-9. PubMed ID: 27510778
[TBL] [Abstract][Full Text] [Related]
15. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
Wu SY; Tan Y; Guan YS
Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
[TBL] [Abstract][Full Text] [Related]
16. Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosis.
Li S; Shen Y; Wang M; Yang J; Lv M; Li P; Chen Z; Yang J
Oncotarget; 2017 May; 8(19):32043-32054. PubMed ID: 28410191
[TBL] [Abstract][Full Text] [Related]
17. Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer.
Garcia-Closas M; Kristensen V; Langerød A; Qi Y; Yeager M; Burdett L; Welch R; Lissowska J; Peplonska B; Brinton L; Gerhard DS; Gram IT; Perou CM; Børresen-Dale AL; Chanock S
Int J Cancer; 2007 Dec; 121(11):2532-8. PubMed ID: 17683073
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of risk factors of axillary lymph node metastasis and prognosis in T1 breast cancer: a large-scale retrospective study based on the SEER database].
Wang WY; Meng XZ; Li N; Zeng HM; Liu JX; Feng KX; Wang PL; Wang X
Zhonghua Yi Xue Za Zhi; 2021 Jul; 101(27):2152-2158. PubMed ID: 34275251
[No Abstract] [Full Text] [Related]
19.
Gupta I; Ouhtit A; Al-Ajmi A; Rizvi SGA; Al-Riyami H; Al-Riyami M; Tamimi Y
Endocr Connect; 2018 Jan; 7(1):65-77. PubMed ID: 29138235
[TBL] [Abstract][Full Text] [Related]
20. A mathematical prediction model incorporating molecular subtype for risk of non-sentinel lymph node metastasis in sentinel lymph node-positive breast cancer patients: a retrospective analysis and nomogram development.
Wang NN; Yang ZJ; Wang X; Chen LX; Zhao HM; Cao WF; Zhang B
Breast Cancer; 2018 Nov; 25(6):629-638. PubMed ID: 29696563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]